This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Study of Pathways Curriculum for Use With WPD

This study has been completed.
Sponsor:
Collaborator:
Portland State University
Information provided by (Responsible Party):
Dena Hassouneh, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT00788814
First received: November 10, 2008
Last updated: October 15, 2012
Last verified: October 2012
  Purpose
Study to assess the efficacy of a modified Pathways curriculum in treating depressive symptoms in women with physical disabilities.

Condition Intervention
Depression Behavioral: Pathways

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Women Physical Disability and Depression: Communities Responding Now!

Further study details as provided by Dena Hassouneh, Oregon Health and Science University:

Primary Outcome Measures:
  • Center for Epidemiologic Studies Depression Scale (CES-D) [ Time Frame: pre-test, post-test weeks, 12, 18, 24 ]

Enrollment: 80
Study Start Date: June 2008
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Control
Control group
Behavioral: Pathways
Strength-based curriculum addressing depression in women with with physical disabilities

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Women with physical disability requiring accommodation for major mobility limitations
  • CES-D score of 16 or higher -

Exclusion Criteria:

  • Active suicidality
  • Diagnosis of Schizophrenia, Schizoaffective D/O, Psychosis NOS
  • Currently receiving other psychotherapy -
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00788814

Locations
United States, Oregon
Oregon Health & Science University
Portland, Oregon, United States, 97236
Sponsors and Collaborators
Oregon Health and Science University
Portland State University
Investigators
Principal Investigator: Dena M Hassouneh, PhD Oregon Health and Science University
  More Information

Responsible Party: Dena Hassouneh, Associate Professor, Oregon Health and Science University
ClinicalTrials.gov Identifier: NCT00788814     History of Changes
Other Study ID Numbers: 1R01MH079818-01A1 ( US NIH Grant/Contract Award Number )
Study First Received: November 10, 2008
Last Updated: October 15, 2012

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on June 23, 2017